Purolite’s increased bioprocessing resin production is designed to meet the growing demand for biopharmaceutical products globally, according to the Ecolab company. The manufacturing expansion reportedly will triple the production capacity of the company’s specialty resins following increased investment in its facilities and workforce.
The new facility is designed to connect Purolite’s applications experts with customers to help solve their pressing challenges. Included in the expansion is increased office space, training areas and conference room facilities.
His Majesty’s Lord-Lieutenant of Mid Glamorgan and Deputy Mayor Wendy Lewis of Rhondda Cynon Taf Council were among those marking the milestone at the facility alongside Gergely Sved, EVP and group president of Ecolab Life Sciences and Healthcare, Hayley Crowe, senior vice president and general manager of Purolite and Chris Major, general manager for Purolite Bioprocessing.
“We have ambitious plans in South Wales and now, more than ever, we are focused on supporting Wales’ extensive commercial potential, both through attracting external investment to the area and supporting our employees in their career and skills development,” says Major in a press release from the company. "As we significantly increase our current processing production output, we are turning that into further investment for unlocking key talent available in Wales. In fact, by the end of 2022, we expect to have increased our local employee population by over 55%.”
Read the press release at: www.purolite.com